Navigation Links
Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008
Date:7/24/2008

PRINCETON, N.J., July 24 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services, will release its second quarter 2008 financial results on Thursday, July 31, 2008 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss the results at 10:00 a.m. EDT on the same day. Management will discuss financial results for the second quarter 2008 as well as operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the live or archived webcast.

Conference Call Details

Date and Time: Thursday, July 31, 2008 at 10:00 a.m. EDT

Dial-In: US/Canada: (877) 266-0703

Int'l/Local: (706) 643-7682

Conference ID: 57573304

Webcast: Live webcast and replay available via the Investor Relations section of the company's website at http://www.orchidcellmark.com. The webcast will be available for 90 days.

About Orchid Cellmark

Orchid Cellmark (Nasdaq: ORCH) is a leading international provider of DNA testing services primarily for forensic and family relationship applications. Orchid Cellmark is one of the largest providers of forensic DNA testing services and its DNA results are used by the criminal justice system to assist with the identification of perpetrators, the exclusion of su
'/>"/>

SOURCE Orchid Cellmark Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Orchid Cellmark Reports First Quarter 2008 Financial Results
2. Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services
3. Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results
4. Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
5. Orchid Cellmark Appoints William J. Thomas Vice President and General Counsel
6. Orchid Cellmark Reports Third Quarter 2007 Financial Results
7. China Medical Technologies to Announce Financial Results for the First Quarter Ended June 30, 2008 on August 4, 2008
8. BD Announces Results for Third Fiscal Quarter
9. Gerbig Engineering Announces Availability of Cleanroom Utility Panel
10. The Palomino Group Announces Launch of Meeting Support Services Business Unit
11. Misys Announces Preliminary Results for the Year Ended 31 May 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... most comprehensive analyses to date of the cost of ... found that this now-dominant surgical approach is significantly more ... of long-term improved patient outcomes. The results of the ... July issue of the journal Urology . ... actual direct and indirect costs at a single institutionrather ...
(Date:5/23/2012)... antioxidant urate to protect against the neurodegeneration caused ... than urate,s ability to protect against oxidative damage. ... journal PLoS One , researchers from the ... suggesting the involvement of a novel mechanism in ... damage. , "Our experiments showed, unexpectedly, that ...
(Date:5/23/2012)... Researchers from The Miriam Hospital,s Weight Control and Diabetes Research ... to eat more meals and snacks, consume more calories per ... sugary foods. , Their study, published online by the ... June issue, reveals certain variations within the FTO and BDNF ... may play a role in eating habits that can cause ...
(Date:5/23/2012)... second edition of Law and the American Health Care ... 2012. Building on its 1997 predecessor, the second edition ... intersection of law and the U.S. health care system. ... a time of unprecedented change in how health care ... of study, the book focuses on how a dramatically ...
(Date:5/23/2012)... (May 23, 2012) The British Association for ... best methods to treat substance abuse and addiction ... by SAGE. A panel of experts has carefully ... detailed review of the evidence to help them ... guidelines target treatment of substance abuse, harmful use, ...
Breaking Medicine News(10 mins):Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Study supports urate protection against Parkinson's disease, hints at novel mechanism 2Health News:'Obesity genes' may influence food choices, eating patterns 2Health News:Landmark textbook on health care and the US legal system released 2Health News:British experts update addiction treatment guidelines 2
... use of antioxidant supplements during radiation and chemotherapy because ... researchers concluded in a commentary published online May 27 ... . , Radiation and many chemotherapy agents work to ... and proteins. Therefore, there is a possibility that taking ...
... days off, poor-quality output, study finds , , TUESDAY, May ... hyperactivity disorder (ADHD) miss, on average, more than three ... new global reckoning of the problem. , Altogether, between ... ADHD, according to survey data from the World Health ...
... higher in low-expenditure areas than in high-expenditure ones, study ... levels of spending on medical care don,t improve patients, ... who conducted a survey of Medicare beneficiaries. , Per ... United States and differences in health don,t account for ...
... that many American kids are still too heavy, , , TUESDAY, ... the first good news in the battle against obesity among ... that the number of overweight kids may be leveling off. ... to improve the health of American children because the number ...
... of Enzyte Restructures Organization, CINCINNATI, May 27 ... seeing positive results.,Consumers are continuing to order their brands ... economic downturn, BPN has hired 70 employees in the,last ... their call center by the end,of ,08. Plans are ...
... the infrastructure for MRF,s collaborative ... ... Collaborative Drug,Discovery, Inc. (CDD) announced today that its web-based ... drug,candidates, has been selected by the Myelin Repair Foundation (MRF) ...
Other Medicine News:Health News:Antioxidant supplements may lessen benefit of radiation and chemotherapy 2Health News:Adults With ADHD Lose 3 Weeks Worth of Work Annually 2Health News:Adults With ADHD Lose 3 Weeks Worth of Work Annually 3Health News:Spending Doesn't Improve Patients' Perception of Care 2Health News:Childhood Obesity May Be Leveling Off 2Health News:Childhood Obesity May Be Leveling Off 3Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 2Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 3Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 4
(Date:5/23/2012)... -- According to Cold Chain IQ ... excursions in 6% or more of their temperature ... can not only result in product losses, but ... IQ presents a new report examining temperature excursions ... products and leading strategies that the pharmaceutical industry ...
(Date:5/22/2012)... SmallCapVoice.com, Inc. announced today that ... Inc. (PINKSHEETS: MJNA) is now available. The ... . Recent company activity and ... income of approximately $1.21 million on gross ... ended March 31, 2012.  This represents a ...
(Date:5/22/2012)... -- Prime Therapeutics (Prime), a leading pharmacy benefit manager, ... chief financial officer (CFO). DuCharme will lead Prime,s finance ... growth. "Jim brings deep health plan expertise ... within diverse health plans, including Blue Cross and Blue ... Prime. "Based on his strong belief in pharmacy as ...
Breaking Medicine Technology:New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 3Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 4Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 1Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 2Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 3Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 4Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 5Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 6Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 7Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 1Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 2Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 3Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 4Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 5Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 6Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 7Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 1Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 2Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 3
... Survival, Disease Control and Neurotoxicity Data To Be ... Support Picoplatin as a Neuropathy-Sparing Alternative to Oxaliplatin ... Management Team to Host Analyst and Investor Briefing ... SOUTH SAN FRANCISCO, Calif., May 28 Poniard ...
... additional analyses from the Phase II portion of a ... for the treatment of acute heart failure will be ... of the Heart Failure Association of the European Society ... professor of cardiology at the University of Brescia, Italy, ...
Other Medicine Technology:Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 5Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 6Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: